-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Immunogenicity of the 13-Valent Pneumococcal Conjugated Vaccine Followed by the 23-Valent Polysaccharide Vaccine in Chronic Lymphocytic Leukemia
Haggenburg, S., Garcia Garrido, H. M., Kant, I. M. J., van der Straaten, H. M., de Boer, F., Kersting, S., Issa, D., te Raa, D., Visser, H. P. J., Kater, A. P., Goorhuis, A. & de Heer, K., 1 Jul 2023, In: Vaccines. 11, 7, 1201.Research output: Contribution to journal › Article › Academic › peer-review
-
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
COBRA KAI Study Team, 1 Oct 2022, In: JAMA Oncology. 8, 10, p. 1477-1483 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications